HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhua Wang Selected Research

Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)

10/2014TRAF4 participates in Wnt/β-catenin signaling in breast cancer by upregulating β-catenin and mediating its translocation to the nucleus.
6/2013TRAF2 regulates the cytoplasmic/nuclear distribution of TRAF4 and its biological function in breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Enhua Wang Research Topics

Disease

101Neoplasms (Cancer)
01/2023 - 08/2002
53Lung Neoplasms (Lung Cancer)
11/2021 - 05/2003
50Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 02/2003
30Lymphatic Metastasis
11/2014 - 08/2002
26Neoplasm Metastasis (Metastasis)
01/2018 - 08/2002
24Breast Neoplasms (Breast Cancer)
05/2022 - 10/2011
10Adenocarcinoma
11/2014 - 02/2004
10Carcinogenesis
09/2014 - 02/2004
9Adenocarcinoma of Lung
09/2020 - 10/2008
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2011 - 02/2004
4Fanconi Anemia (Fanconi's Anemia)
05/2022 - 01/2012
3Colorectal Neoplasms (Colorectal Cancer)
09/2021 - 06/2013
3Urinary Bladder Neoplasms (Bladder Cancer)
03/2017 - 11/2012
3Ovarian Neoplasms (Ovarian Cancer)
10/2015 - 01/2012
3Carcinoma (Carcinomatosis)
05/2015 - 08/2002
3Ovarian Epithelial Carcinoma
08/2014 - 01/2012
3Pulmonary Sclerosing Hemangioma
04/2006 - 04/2003
2Stomach Neoplasms (Stomach Cancer)
04/2019 - 01/2017
2Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
02/2013 - 11/2012
2Inflammation (Inflammations)
01/2013 - 11/2011
2Hypoxia (Hypoxemia)
10/2008 - 10/2008
2Giant Cell Carcinoma
06/2008 - 04/2008
1Bicuspid Aortic Valve Disease
01/2023
1Aortic Valve Stenosis (Aortic Stenosis)
01/2023

Drug/Important Bio-Agent (IBA)

55Proteins (Proteins, Gene)FDA Link
11/2021 - 08/2002
21CateninsIBA
01/2023 - 02/2004
21Cadherins (E-Cadherin)IBA
01/2018 - 08/2002
16Small Interfering RNA (siRNA)IBA
01/2020 - 10/2008
14Messenger RNA (mRNA)IBA
11/2021 - 08/2002
14Delta CateninIBA
01/2018 - 08/2005
9DNA (Deoxyribonucleic Acid)IBA
05/2022 - 03/2009
9Biomarkers (Surrogate Marker)IBA
01/2019 - 12/2012
9Cyclin D1IBA
01/2018 - 01/2012
6Phosphotransferases (Kinase)IBA
11/2021 - 10/2011
6VimentinIBA
08/2015 - 04/2004
5Protein Isoforms (Isoforms)IBA
01/2014 - 04/2008
5MicroRNAs (MicroRNA)IBA
06/2013 - 09/2009
5beta CateninIBA
09/2010 - 08/2002
4AntibodiesIBA
10/2021 - 06/2005
3Keratins (Keratin)IBA
01/2021 - 04/2004
3Caspase 3 (Caspase-3)IBA
08/2020 - 08/2012
3Matrix Metalloproteinases (MMPs)IBA
03/2017 - 01/2014
3Cisplatin (Platino)FDA LinkGeneric
03/2017 - 08/2013
3MethyltransferasesIBA
09/2015 - 01/2012
3DesminIBA
08/2015 - 01/2015
3AntigensIBA
09/2012 - 02/2004
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2009 - 01/2009
3Vascular Endothelial Growth Factor CIBA
08/2009 - 05/2003
2Alkylating AgentsIBA
05/2022 - 07/2014
2Neurofibromin 2 (Merlin)IBA
11/2021 - 01/2020
2Mucin-1 (CA 15-3 Antigen)IBA
01/2021 - 04/2004
2Long Noncoding RNAIBA
09/2020 - 01/2020
2NF-kappa B (NF-kB)IBA
02/2018 - 01/2012
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
02/2018 - 01/2014
2Cyclin A2IBA
01/2018 - 09/2015
2Fluorouracil (Carac)FDA LinkGeneric
01/2017 - 07/2013
2ErbB Receptors (EGF Receptor)IBA
08/2016 - 01/2013
2Estrogen Receptor alphaIBA
09/2015 - 09/2012
2Methionine EnkephalinIBA
01/2015 - 03/2014
2Adenosine Triphosphate (ATP)IBA
01/2015 - 06/2013
2AnthracyclinesIBA
01/2015 - 09/2012
2Chemokine ReceptorsIBA
12/2014 - 10/2008
2TNF Receptor-Associated Factor 4IBA
10/2014 - 06/2013
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
10/2014 - 06/2013
2SurvivinIBA
07/2014 - 08/2012
2Caspase 8 (Caspase-8)IBA
07/2014 - 11/2013
2Indicators and Reagents (Reagents)IBA
12/2013 - 01/2013
2A-Form DNA (A-DNA)IBA
09/2013 - 01/2012
2Guanosine Triphosphate (GTP)IBA
05/2013 - 05/2009
2CytokinesIBA
01/2013 - 08/2012
2VaccinesIBA
11/2012 - 09/2012
2Cyclin EIBA
10/2012 - 01/2012
2Estrogens (Estrogen)FDA Link
09/2012 - 09/2012
2ParaffinIBA
08/2012 - 10/2004
2Focal Adhesion Kinase 2IBA
08/2012 - 12/2008
2Formaldehyde (Formol)FDA Link
08/2012 - 10/2004
2Interleukin-7 Receptors (Interleukin 7 Receptor)IBA
01/2012 - 03/2009
2CC ChemokinesIBA
01/2012 - 01/2011
2Interleukin-7 (Interleukin 7)IBA
01/2012 - 03/2009
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
09/2011 - 06/2007
2integrin-linked kinaseIBA
01/2011 - 08/2005
2heparanaseIBA
08/2009 - 02/2004
2Monomeric GTP-Binding ProteinsIBA
05/2009 - 04/2009
2Guanine NucleotidesIBA
08/2008 - 06/2008
2Biological FactorsIBA
12/2004 - 02/2004
2Surface-Active Agents (Surfactants)IBA
04/2004 - 04/2003
2IgA receptor (protein B)IBA
04/2004 - 04/2003
1GinsenosidesIBA
01/2023
1ProdrugsIBA
01/2023
1RNA (Ribonucleic Acid)IBA
10/2022
1extracellular matrix receptorIBA
10/2022
1Cysteine (L-Cysteine)FDA Link
11/2021
1Connective Tissue Growth FactorIBA
11/2021
1Inhibins (Inhibin)IBA
11/2021
1Rituximab (Mabthera)FDA Link
10/2021

Therapy/Procedure

10Drug Therapy (Chemotherapy)
11/2015 - 02/2003
9Therapeutics
05/2016 - 09/2010
3Immunotherapy
01/2015 - 11/2012
2Radiotherapy
08/2017 - 08/2012
1Transcatheter Aortic Valve Replacement
01/2023